{
  "ticker": "EWTX",
  "company_name": "Edgewise Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT07034768",
      "title": "A Study to Evaluate EDG-7500 in People With Renal Impairment",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Renal Impairments",
      "start_date": "2025-07-22",
      "completion_date": "2025-12-31",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06916897",
      "title": "A Study to Evaluate Effect of Verapamil and Food of Sevasemten in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Subjects",
      "start_date": "2025-01-08",
      "completion_date": "2025-02-22",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04349566",
      "title": "Fast Troponin as a Biomarker to Assess Exercise-induced Muscle Damage in Muscle Diseases",
      "status": "COMPLETED",
      "phase": "",
      "condition": "Becker Muscular Dystrophy, McArdle Disease, Limb-Girdle Muscular Dystrophy Type 2",
      "start_date": "2020-06-01",
      "completion_date": "2021-12-20",
      "enrollment": 0,
      "sponsor": "Mads Peter Godtfeldt Stemmerik"
    },
    {
      "nct_id": "NCT05730842",
      "title": "Absorption, Metabolism, Excretion and Absolute Bioavailability of EDG-5506 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, Inborn",
      "start_date": "2023-01-12",
      "completion_date": "2023-04-06",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05540860",
      "title": "A Study of EDG-5506 in Children With Duchenne Muscular Dystrophy (LYNX)",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE2",
      "condition": "Duchenne Muscular Dystrophy",
      "start_date": "2022-10-24",
      "completion_date": "2027-01",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT06738836",
      "title": "A Study to Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C]-EDG-7500",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer",
      "start_date": "2024-12-03",
      "completion_date": "2025-01-17",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT07324616",
      "title": "A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1",
      "condition": "Hepatic Impairment (HI)",
      "start_date": "2026-01",
      "completion_date": "2026-05",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT05257473",
      "title": "Defining Endpoints in Becker Muscular Dystrophy",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "",
      "condition": "Becker Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy in Children, Muscular Dystrophy, Becker",
      "start_date": "2022-04-13",
      "completion_date": "2026-05",
      "enrollment": 0,
      "sponsor": "Virginia Commonwealth University"
    },
    {
      "nct_id": "NCT07177066",
      "title": "A Study of EDG-15400 in Healthy Adults",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Healthy Adults",
      "start_date": "2025-08-20",
      "completion_date": "2026-05",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    },
    {
      "nct_id": "NCT04585464",
      "title": "A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Healthy Volunteer, Becker Muscular Dystrophy",
      "start_date": "2020-10-12",
      "completion_date": "2021-12-27",
      "enrollment": 0,
      "sponsor": "Edgewise Therapeutics, Inc."
    }
  ],
  "summary": {
    "total_trials": 17,
    "by_phase": {
      "PHASE1": 10,
      "": 2,
      "PHASE2": 5
    },
    "by_status": {
      "RECRUITING": 3,
      "COMPLETED": 8,
      "ACTIVE_NOT_RECRUITING": 4,
      "NOT_YET_RECRUITING": 1,
      "ENROLLING_BY_INVITATION": 1
    },
    "active_trials": 8,
    "completed_trials": 8,
    "conditions": [
      "Becker Muscular Dystrophy",
      "Becker Muscular Dystrophy, McArdle Disease, Limb-Girdle Muscular Dystrophy Type 2",
      "Becker Muscular Dystrophy, Muscular Dystrophies, Muscular Dystrophy in Children, Muscular Dystrophy, Becker",
      "Duchenne Muscular Dystrophy",
      "Healthy Adults",
      "Healthy Subjects",
      "Healthy Volunteer",
      "Healthy Volunteer, Becker Muscular Dystrophy",
      "Healthy Volunteer, Muscular Dystrophies, Muscular Disorders, Atrophic, Muscular Diseases, Musculoskeletal Diseases, Neuromuscular Diseases, Nervous System Diseases, Genetic Diseases, Inborn",
      "Hepatic Impairment (HI)",
      "Hypertrophic Cardiomyopathy",
      "Muscular Dystrophies",
      "Renal Impairments"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:18.259887",
    "search_query": "Edgewise Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Edgewise+Therapeutics,+Inc."
  }
}